INFOS !
  • NEW ADDRESS: The management team of ERN-EYE is moving! Starting from March 19, you can find us at 1 Rue Eugène Boeckel, 67000 Strasbourg.

Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

USTEKINISU

In this page

Clinical Trial

NCT03847272 Terminated
USTEKINISU

A multicenter phase 2 single-arm proof-of-concept trial assessing the efficacy and safety of ustekinumab in association with prednisone, for the treatment of non-infectious severe uveitis (NISU)

Phase 2
Interventional

Disease

Disease type

Uveitis

Orphan drug recognition

Yes

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

01/08/2019

Closing date

25/10/2023

Inclusion criteria :

More

Exclusion criteria :

More

Funding

public